Results 151 to 160 of about 42,543 (244)

The Possible Role of Immunotherapy in Locally Advanced Pancreatic Cancer Treatment. [PDF]

Acta Med Acad
Barakat R, Sidira D, Stavropoulos A, Konsolas N, Palantzas A, Filippou D.   +5 more
europepmc   +1 more source

Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.

, 1988
Salem Chouaı̈b, Jacques Bertoglio, Jean‐Yves Blay, Carmen Marchiol, D Fradelizi   +4 more
openalex   +2 more sources

Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia. [PDF]

Front Oncol
Cheng C, Mi R, Li D, Chen L, Wei X.
europepmc   +1 more source

Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules

, 1992
Flavio Arienti, Carlo Gambacorti‐Passerini, Lorenza Borin, Licia Rivoltini, Attilio Orazi, Enrico Maria Pogliani, G. Corneo, Giorgio Parmiani   +7 more
openalex   +1 more source

Comparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers: focus on melanoma, mast cell tumors, and squamous cell carcinoma. [PDF]

Front Immunol
Mârza SM, Munteanu C, Papuc I, Purdoiu RC.   +3 more
europepmc   +1 more source

The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression. [PDF]

Biomolecules
Tang J, Lu Y, Chen M, Wu Q, Li Y, Qin Y, Liang S, Luo S, Liu K.   +8 more
europepmc   +1 more source

Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: Possible application for compensatory anti-inflammatory response syndrome

, 2006
Yoshiyuki Yamaguchi, Jun Hihara, Katsuji Hironaka, Akiko Ohshita, Riki Okita, Makoto Okawaki, Kazuo Matsuura, Ichiro Nagamine, Takuhiro Ikeda, Masahiro Ohara, Yoichi Hamai   +10 more
openalex   +2 more sources

Anti-tumor activity and production of cytotoxic factor by Lymphokine-activated killer cells

, 1987
J Gangi
openalex   +2 more sources

From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization. [PDF]

Cell Commun Signal
Rao D, Wang T, Fu C, Luo Y, Lu J, Sun Z, Yan W, Liang H, Xia L, Huang W.   +9 more
europepmc   +1 more source

Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms

, 2004
J. Funk, Gabriele Schmitz, Klaus Failing, Eberhard Burkhardt   +3 more
openalex   +2 more sources